Primary tumour | Liver metastases | Clinical outcome | |||||
---|---|---|---|---|---|---|---|
No. | Type | Treatment | Tumour burden | Largest diameter | Response | Status | Laboratory characterisation of exosomes |
1 | Choroidal | I-125 | 10-24% | 15 mm | PR | Alive 29 mo | RNA, FACS, PCR |
2 | Choroidal | En | 25-50% | 25 mm | PR | Dead 25 mo | RNA |
3 | Choroidal | I-125 + En | 10-24% | 45 mm | PR | Dead 17 mo | RNA |
4 | Choroidal | En | <10% | 20 mm | PR | Alive 17 mo | EM |
5 | Choroidal | En | <10% | 55 mm | PR | Dead 14 mo | EC, RNA, PCR |
6 | Choroidal | En | 10-24% | 35 mm | PR | Alive 13 mo | EC, RNA, FACS |
7 | Choroidal | I-125 | <10% | 23 mm | SD | Alive 13 mo | EC, RNA, PCR |
8 | Choroidal | Ru-106 | 25-50% | 100 mm | PD | Alive 11 mo | EC, RNA, PCR, FACS |
9 | Choroidal | En | <10% | 40 mm | PR | Alive 10 mo | EC, RNA, PCR |
10 | Choroidal | Ru-106 + En | <10% | 30 mm | SD | Alive 7 mo | EC |
11 | Choroidal | En | <10% | 15 mm | SD | Alive 6 mo | EC |
12 | Choroidal | En | 10-24% | 25 mm | PR | Alive 5 mo | EC |